Anti-F10 & F9 activated form重组抗体|科研级 Emicizumab ( 依米赛珠单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-F10 & F9 activated form重组抗体|科研级 Emicizumab ( 依米赛珠单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-F10 & F9 activated form重组抗体|科研级 Emicizumab ( 依米赛珠单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1383

Alias

科研级 Emicizumab ( 依米赛珠单抗 ), Anti-F10 & F9 activated form Recombinant Antibody, Research Grade Emicizumab

Molecular Name

Emicizumab

Size

1mg, 5mg

CAS Number

1610943-06-0

Isotype

IgG4 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6434H9940N1724O2047S45

Target

F10/F9 activated form[Homo sapiens]

Background

Emicizumab (trade name Hemlibra) is a humanized bispecific antibody for the treatment of haemophilia A, developed by Genentech and Chugai (a subsidiary of Roche). A Phase I clinical trial found that it was well tolerated by healthy subjects.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ